You left the moldy house. You moved out of the water-damaged office. You threw away the contaminated belongings. But weeks or months later, you still feel terrible. Your doctor says your environment is fine now, so you should be getting better. Yet the fatigue, the brain fog, the joint pain, and the strange neurological symptoms persist. If this sounds familiar, you may be dealing with Chronic Inflammatory Response Syndrome, and you are not imagining it.<\/p>\n
Chronic Inflammatory Response Syndrome (CIRS) is a multi-system, multi-symptom illness caused by exposure to biotoxins, most commonly from water-damaged buildings. The condition was first characterized by Dr. Ritchie Shoemaker, a family physician in Maryland who spent decades identifying the biological mechanisms behind mold-related illness.<\/p>\n
CIRS is not an allergy to mold. It is not a psychological condition. It is a measurable, documentable inflammatory response in which the innate immune system becomes chronically activated and cannot shut itself off. The inflammation affects virtually every organ system in the body, which is precisely why patients often see dozens of specialists without getting answers.<\/p>\n
The illness affects an estimated 25% of the population who carry specific genetic markers (more on that below). For these individuals, exposure to the toxins produced by certain molds, bacteria, and other organisms in water-damaged buildings triggers a cascade of immune dysfunction that can persist long after the exposure has ended.<\/p>\n
To understand why CIRS patients remain sick even after leaving a moldy environment, you need to understand mycotoxins and the biotoxin pathway.<\/p>\n
Mold species like Stachybotrys chartarum<\/em> (black mold), Aspergillus<\/em>, Penicillium<\/em>, and Chaetomium<\/em> produce secondary metabolites called mycotoxins. These are extremely small molecules that become airborne as fragments, spores, and volatile organic compounds. They enter the body through inhalation, skin contact, and ingestion.<\/p>\n In a healthy person with normal immune genetics, the body tags these biotoxins with antibodies, presents them to the immune system, and clears them through the liver and kidneys. The process works efficiently. The person may feel a bit off during exposure but recovers quickly once removed from the source.<\/p>\n In a genetically susceptible person, the story is entirely different. Their immune system cannot properly recognize and tag these biotoxins for removal. The toxins circulate continuously through the body, triggering an ongoing inflammatory response. Cytokines rise. Complement activation occurs. Hormones regulated by the hypothalamus become disrupted. The result is a self-perpetuating cycle of inflammation that does not resolve on its own, even years after the original exposure.<\/p>\n This is why “just leaving the moldy building” is not enough for many patients. The biotoxins are already embedded in the system, and without proper intervention, the inflammatory cascade continues indefinitely.<\/p>\n One of the most frustrating aspects of mold illness is the social dynamic. You lived in the same house as your partner, your kids, or your roommates. They feel fine. You can barely function. This discrepancy leads many doctors (and sometimes family members) to conclude that your symptoms must be psychosomatic.<\/p>\n The explanation is genetic, and it is measurable through a blood test.<\/p>\n The HLA-DR (Human Leukocyte Antigen) gene system controls how your immune system identifies and processes foreign substances. Specific HLA-DR haplotypes make certain individuals unable to properly present biotoxins to their adaptive immune system. Research from Shoemaker and others has identified multiple “mold-susceptible” haplotypes that appear in roughly 24-25% of the general population.<\/p>\n If you carry one of these susceptible haplotypes, your body essentially has a blind spot for biotoxins. Your immune system knows something is wrong (it mounts an inflammatory response), but it cannot identify and eliminate the specific threat. This leads to chronic, unregulated inflammation rather than a targeted immune response.<\/p>\n Approximately 2% of the population carries a “dreaded” multi-susceptible haplotype that makes them reactive to multiple biotoxin sources, not just mold. These individuals tend to have the most severe presentations and the most complex recovery paths.<\/p>\n CIRS is often called the “great mimicker” because its symptoms overlap with dozens of other conditions. Shoemaker’s research identified 37 symptoms organized into 13 clusters. To meet clinical criteria for CIRS, a patient typically presents with symptoms in at least 8 of these 13 clusters.<\/p>\n The symptom clusters include:<\/p>\n Many patients report that their symptoms seem to shift and change over time, with different systems flaring at different points. This variability often leads to misdiagnosis or the dismissive conclusion that the symptoms are “all in your head.”<\/p>\n If you have been diagnosed with (or suspect) Mast Cell Activation Syndrome (MCAS)<\/a>, histamine intolerance<\/a>, or chronic brain fog<\/a>, CIRS should be on your radar as a potential root cause or contributing factor.<\/p>\n The connection between CIRS and mast cell activation is direct and well-documented. The chronic inflammatory state in CIRS activates mast cells throughout the body, causing them to degranulate and release histamine, prostaglandins, leukotrienes, and other inflammatory mediators. This is why many CIRS patients develop new food sensitivities, chemical sensitivities, and histamine reactions that they never had before their mold exposure.<\/p>\n The neurological symptoms of CIRS, particularly brain fog, are driven by multiple mechanisms. Inflammatory cytokines cross the blood-brain barrier and activate microglial cells (the brain’s immune cells). Reduced blood flow through the capillary beds (measurable through VO2 max and VEGF testing) starves brain tissue of oxygen. Disrupted levels of vasoactive intestinal peptide (VIP), melanocyte-stimulating hormone (MSH), and antidiuretic hormone (ADH) further impair cognitive function.<\/p>\n The vagus nerve<\/a> also plays a role. Chronic inflammation in CIRS disrupts vagal tone, which can contribute to the autonomic dysfunction, digestive problems, and mood disturbances seen in many patients. Vagus nerve impairment may help explain why CIRS patients often develop POTS-like symptoms<\/a>, including tachycardia, blood pressure instability, and exercise intolerance.<\/p>\n Understanding these connections is important because treating MCAS or histamine intolerance alone, without addressing the underlying CIRS, often produces incomplete or temporary results. The mast cells will continue to be activated as long as the biotoxin-driven inflammation persists.<\/p>\n One of the most validating aspects of CIRS for patients who have been dismissed is the extensive panel of objective lab tests that can document the illness. CIRS is not a clinical diagnosis based solely on symptoms. It is supported by measurable, reproducible biomarkers.<\/p>\n The VCS test is a simple screening tool that measures your ability to distinguish between shades of gray at varying contrasts. Biotoxin exposure affects the neurological pathways involved in contrast detection. Research shows that the VCS test has a sensitivity of approximately 92% for identifying biotoxin-affected patients. It can be done online as a preliminary screen, though in-office testing is more accurate.<\/p>\n A blood test that identifies whether you carry one of the mold-susceptible haplotypes. This test does not diagnose CIRS on its own, but it establishes genetic susceptibility and helps explain why you became sick while others in the same environment did not.<\/p>\n The core CIRS lab panel includes markers that most conventional doctors do not routinely order:<\/p>\n
\nIn genetically susceptible individuals, biotoxins cannot be tagged and cleared by the immune system. They circulate continuously, triggering a self-perpetuating inflammatory cascade. Without binder therapy and the full treatment protocol, the inflammation persists indefinitely – even years after the exposure has ended.\n<\/div>\nWhy Some People Get Sick and Others Don’t: HLA-DR Genetics<\/h2>\n
Symptoms of CIRS: A Multi-System Disease<\/h2>\n
\n
The CIRS Connection to MCAS, Histamine, and Brain Fog<\/h2>\n
Testing for CIRS: Objective, Measurable Biomarkers<\/h2>\n
Visual Contrast Sensitivity (VCS) Test<\/h3>\n
\nThe Visual Contrast Sensitivity (VCS) test has approximately 92% sensitivity for detecting biotoxin-affected patients. It can be completed online in minutes as a preliminary screen. While not diagnostic on its own, a positive result combined with multi-system symptoms and a history of water-damaged building exposure is a strong signal to pursue formal CIRS testing.\n<\/div>\nHLA-DR Genotyping<\/h3>\n
Inflammatory Biomarker Panel<\/h3>\n
\n